Conversely, high levels of NOTCH1 correlate with increased resistance to cisplatin in HNSCC patients [100], while high expression of both NOTCH1 and JAG1 (a NOTCH 1 ligand) is associated with poor prognosis in HNSCC [101]. Here, JAG1 is linked to head and neck squamous cell carcinoma.